Skip to content

Human application test to evaluate blood sugar improvement and health promotion effect by participating in lifestyle improvement program in diabetics

Human application test to evaluate blood sugar improvement and health promotion effect by participating in lifestyle improvement program in diabetics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005313
Enrollment
30
Registered
2020-08-19
Start date
2018-05-31
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : ? The test group participates in a total of two lifestyle improvement programs. ? 1st LSI program session: two nights and three day (28 hours) - 1 day program Time Program 10:0

Sponsors

Chonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Male and female adults aged 19 or older at the time of the screening test (2) Diabetes diagnosed at the time of screening (6.5%= HbA1c < 9.0%) (3) Those who have heard and fully understood the detailed description of this human study and have agreed in writing to decide his/her own participation and to comply with the precautions

Exclusion criteria

Exclusion criteria: (1) Patients with type 1 diabetes and type 2 diabetes who have had or are administering insulin medications within the last 3 months. (2) Patients with clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal system, inflammatory and blood and tumor diseases. (3) Patients with a history of gastrointestinal diseases (such as Crohn's disease) or gastrointestinal surgery (except simple appendectomy or hernia surgery) that can affect the absorption of nutrients (4) Those who are unable to participate in the lifestyle intervention program (LSI), such as dietary intake and exercise prescriptions according to dietary prescriptions (5) Those who continue to take anti-psychotic drugs or narcotic analgesics within six months prior to the screening test (6) Those suspected of alcoholism or drug abuse or who has a history (7) Those who showed the following results in a diagnostic examination ? Serum AST, ALT > three times the upper limit of the reference range ? Serum creatinine > 2.0mg/dL (8) Those who participated in another human study within two months before the screening test (9) Screening tests show that pregnant women, breast feeding women, and possibly pregnant patients (if the menstrual period lasts at least 12 months, it shall be regarded as menopause, and if contraceptive method are used using hormone preparations, such as oral contraceptives, they shall be used at the same time from the screening test) do not use appropriate contraception methods (e.g., hormone transplants, intrauterine devices, oral contraceptives, etc.)

Design outcomes

Primary

MeasureTime frame
Blood glucose index (fasting blood glucose, postprandial blood glucose, fasting insulin)

Secondary

MeasureTime frame
Glycated albumin, glycated hemoglobin, insulin resistance index;Body measurement indicator, lipid metabolism indicator, inflammation indicator

Countries

Korea, Republic of

Contacts

Public ContactEun Jung

Chonbuk National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026